Genetic material collected in routine cervical cancer screenings could be used to screen for ovarian cancer several years before disease symptoms are evident, possible speeding diagnosis and treatment, a study suggests. The study, “Detection of TP53 Clonal Variants in Papanicolaou Test Samples Collected up to 6 Years Prior to High-Grade Serous Epithelial Ovarian Cancer Diagnosis,” was published in JAMA Network Open. One of the ongoing challenges regarding ovarian cancer treatment and research is that, often, the cancer…
You must be logged in to read/download the full post.
The post Pap Smear Samples May Aid Early Diagnosis of Common Ovarian Cancer appeared first on BioNewsFeeds.